CASE STUDY

Polly PeakML Speeds Up Insight Derivation from Untargeted Metabolomics

Key Highlights

  • The company aimed to facilitate an initiative for ML-model based classification of untargeted metabolomics data. This approach could then be utilized for investigational therapies in preclinical development.
  • Peak detection in metabolomics studies demands expert evaluation of global profile of metabolites and is a tedious, error-prone process.
  • To help the company gain better insights from the untargeted metabolomics data, Polly PeakML pipeline was used to curate and analyze the data.
  • The company was able to identify correlation between metabolites;  pathways associated with the diseased and rescue conditions and gain many more insights using Polly PeakML.
  • Lastly and importantly, the company was able to perform the task in just a few minutes and the entire analysis in a few weeks!

All Case Studies

Case study: Accelerated Target ID using ML-Ready data on Polly

Elucidata Transforms RNAi Drug Discovery: 2X Faster Gene ID & Cell Annotation

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Elucidata x Hookipa: 7x Faster Insights In Translational Research

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Optimizing Diagnostics: Elucidata Doubles (2X) Sample to Report Speed

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Accelerating Immune Disorder Research with 5M Harmonized Cells

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Elucidata x Celsius: 4x Faster Insights with Single-cell Infra

Read More
Case study: Accelerated Target ID using ML-Ready data on Polly

Polly Delivers STAR Quality Data at High Throughput, 5x Lower Cost

Read More
Request Demo